{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:21Z","timestamp":1786979601950,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00059-021-05025-2","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T09:45:53Z","timestamp":1612950353000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment rationale for coronary heart disease in advanced CKD","Grundprinzip der Therapie der KHK bei fortgeschrittener Niereninsuffizienz"],"prefix":"10.1007","volume":"46","author":[{"given":"K.","family":"Lopau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"issue":"7","key":"5025_CR1","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1681\/ASN.2015050542","volume":"27","author":"K Br\u00fcck","year":"2016","unstructured":"Br\u00fcck\u00a0K, Stel\u00a0VS, Gambaro\u00a0G et\u00a0al (2016) CKD prevalence varies across the European general population. J\u00a0Am Soc Nephrol 27(7):2135\u20132147. https:\/\/doi.org\/10.1681\/ASN.2015050542","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5025_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1523-1755.2002.00432.x","volume":"62","author":"SS Khan","year":"2002","unstructured":"Khan\u00a0SS, Kazmi\u00a0WH, Abichandani\u00a0R et\u00a0al (2002) Health care utilization among patients with chronic kidney disease. Kidney Int 62(1):229\u2013236. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00432.x","journal-title":"Kidney Int."},{"issue":"13","key":"5025_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go\u00a0AS, Chertow\u00a0GM, Fan\u00a0D et\u00a0al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N\u00a0Engl J Med 351(13):1296\u20131305. https:\/\/doi.org\/10.1056\/NEJMoa041031","journal-title":"N Engl J Med"},{"key":"5025_CR4","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita\u00a0K, van der Velde\u00a0M, Astor\u00a0BC et al (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a\u00a0collaborative meta-analysis. Lancet 375:2073\u20132081. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5","journal-title":"Lancet"},{"issue":"4","key":"5025_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein\u00a0HC, Mann\u00a0JF, Zinman\u00a0YQ et\u00a0al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286(4):421\u2013426. https:\/\/doi.org\/10.1001\/jama.286.4.421","journal-title":"JAMA"},{"issue":"14","key":"5025_CR6","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak\u00a0MJ, Amann\u00a0K, Bangalore\u00a0S et al (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J\u00a0Am Coll Cardiol 74(14):1823\u20131838. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1017","journal-title":"J Am Coll Cardiol"},{"key":"5025_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/j.ajkd.2005.11.017","volume":"47","author":"J Sosnov","year":"2006","unstructured":"Sosnov\u00a0J, Lessard\u00a0D, Goldberg\u00a0J et al (2006) Differential symptoms of acute myocardial infarction in patients with kidney disease: a\u00a0community-wide perspective. Am J Kidney Dis 47:378\u2013384. https:\/\/doi.org\/10.1053\/j.ajkd.2005.11.017","journal-title":"Am J Kidney Dis"},{"key":"5025_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.jacc.2011.07.010","volume":"58","author":"AS Go","year":"2011","unstructured":"Go\u00a0AS, Bansal\u00a0N, Chandra\u00a0M et\u00a0al (2011) Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J\u00a0Am Coll Cardiol 58:1600\u20131607. https:\/\/doi.org\/10.1016\/j.jacc.2011.07.010","journal-title":"J Am Coll Cardiol"},{"key":"5025_CR9","doi-asserted-by":"publisher","first-page":"15594","DOI":"10.1093\/eurheartj\/ehp185","volume":"30","author":"MK de Bie","year":"2009","unstructured":"de Bie\u00a0MK, van Dam\u00a0B, Gaasbeek\u00a0A et\u00a0al (2009) The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. Eur Heart\u00a0J 30:15594\u201315564. https:\/\/doi.org\/10.1093\/eurheartj\/ehp185","journal-title":"Eur Heart J"},{"key":"5025_CR10","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.2215\/CJN.02680314","volume":"9","author":"BV Stefansson","year":"2014","unstructured":"Stefansson\u00a0BV, Brunelli\u00a0SM, Cabrera\u00a0C et\u00a0al (2014) Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol 9:2124\u20132132. https:\/\/doi.org\/10.2215\/CJN.02680314","journal-title":"Clin J Am Soc Nephrol"},{"key":"5025_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.ajkd.2011.09.017","volume":"59","author":"DK Packham","year":"2012","unstructured":"Packham\u00a0DK, Alves\u00a0TP, Dwyer\u00a0JP et\u00a0al (2012) Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC database. Am J Kidney Dis 59:75\u201383. https:\/\/doi.org\/10.1053\/j.ajkd.2011.09.017","journal-title":"Am. J. Kidney Dis."},{"key":"5025_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort\u00a0RT, Correa-Rotter\u00a0R, Hemmelgarn\u00a0BR et al (2013) Chronic kidney disease and cardiovascular risk: edpidemiology, mechanisms, and prevention. Lancet 382:339\u2013352. https:\/\/doi.org\/10.1016\/S0140-6736(13)60595-4","journal-title":"Lancet"},{"issue":"14","key":"5025_CR13","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","volume":"293","author":"MG Shlipak","year":"2005","unstructured":"Shlipak\u00a0MG, Fried\u00a0LF, Cushman\u00a0M et\u00a0al (2005) Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293(14):1737\u20131745. https:\/\/doi.org\/10.1001\/jama.293.14.1737","journal-title":"JAMA"},{"key":"5025_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijcard.2016.04.151","volume":"216","author":"SD Anker","year":"2016","unstructured":"Anker\u00a0SD, Gillespie\u00a0IA, Eckardt\u00a0KU et\u00a0al (2016) Development and validation of cardiovascular risk scores for haemodialysis patients. Int J Cardiol 216:68\u201377. https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.151","journal-title":"Int J Cardiol"},{"key":"5025_CR15","doi-asserted-by":"publisher","first-page":"CD008691","DOI":"10.1002\/14651858.CD008691.pub2","volume":"12","author":"LW Wang","year":"2011","unstructured":"Wang\u00a0LW, Fahim\u00a0MA, Hayen\u00a0A et\u00a0al (2011) Cardiac testing for coronay artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev 12:CD8691. https:\/\/doi.org\/10.1002\/14651858.CD008691.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"5025_CR16","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2215\/CJN.01970309","volume":"4","author":"S Beddhu","year":"2009","unstructured":"Beddhu\u00a0S, Baird\u00a0BC, Zitterkoph\u00a0J et\u00a0al (2009) Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol 4:1901\u20131906. https:\/\/doi.org\/10.2215\/CJN.01970309","journal-title":"Clin J Am Soc Nephrol"},{"key":"5025_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/ndt\/gfr364","volume":"27","author":"GC Kosmadakis","year":"2012","unstructured":"Kosmadakis\u00a0GC, John\u00a0SG, Clapp\u00a0EL et al (2012) Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease. Nephrol Dial Transplant 27:997\u20131004. https:\/\/doi.org\/10.1093\/ndt\/gfr364","journal-title":"Nephrol Dial Transplant"},{"key":"5025_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/kisup.2012.66","volume":"3","author":"KDIGO","year":"2013","unstructured":"KDIGO (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Chapter 3: management of progression and complications of CKD. Kidney Int Suppl 3:73\u201390. https:\/\/doi.org\/10.1038\/kisup.2012.66","journal-title":"Kidney Int. Suppl."},{"key":"5025_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM199403313301301","volume":"330","author":"S Klahr","year":"1994","unstructured":"Klahr\u00a0S, Levey\u00a0AS, Beck\u00a0GJ et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N\u00a0Engl J Med 330:877\u2013884. https:\/\/doi.org\/10.1056\/NEJM199403313301301","journal-title":"N Engl J Med"},{"key":"5025_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1053\/j.ajkd.2008.08.009","volume":"53","author":"V Menon","year":"2009","unstructured":"Menon\u00a0V, Kopple\u00a0JD, Wang\u00a0X et al (2009) Effect of a\u00a0very low-protein diet on outcomes: long-term follow-up of the modification of diet in renal disease (MDRD) study. Am J Kidney Dis 53:208\u2013217. https:\/\/doi.org\/10.1053\/j.ajkd.2008.08.009","journal-title":"Am. J. Kidney Dis."},{"key":"5025_CR21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/ki.2013.147","volume":"84","author":"TA Ikizler","year":"2013","unstructured":"Ikizler\u00a0TA, Cano\u00a0NJ, Franch\u00a0H et\u00a0al (2013) Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the international society of renal nutrition and metabolism. Kidney Int 84:1096\u20131107. https:\/\/doi.org\/10.1038\/ki.2013.147","journal-title":"Kidney Int."},{"key":"5025_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000093833","volume":"26","author":"C Jones-Burton","year":"2006","unstructured":"Jones-Burton\u00a0C, Mishra\u00a0SI, Fink\u00a0JC et al (2006) An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol 26:268\u2013275. https:\/\/doi.org\/10.1159\/000093833","journal-title":"Am J Nephrol"},{"key":"5025_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s40620-019-00656-5","volume":"32","author":"BR Di Iorio","year":"2019","unstructured":"Di Iorio\u00a0BR, Bellasi\u00a0A, Raphael\u00a0KL et\u00a0al (2019) Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI study. J\u00a0Nephrol 32:989\u20131001. https:\/\/doi.org\/10.1007\/s40620-019-00656-5","journal-title":"J Nephrol"},{"key":"5025_CR24","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1046\/j.1523-1755.2000.00056.x","volume":"57","author":"AJ Bleyer","year":"2000","unstructured":"Bleyer\u00a0AJ, Shemanski\u00a0LR, Burke\u00a0GI et\u00a0al (2000) Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 57:2072\u20132079. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00056.x","journal-title":"Kidney Int."},{"key":"5025_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/ki.2011.157","volume":"80","author":"SI Hallan","year":"2011","unstructured":"Hallan\u00a0SI, Orth\u00a0SR (2011) Smoking is a\u00a0risk factor in the progression to kidney failure. Kidney Int 80:516\u2013523. https:\/\/doi.org\/10.1038\/ki.2011.157","journal-title":"Kidney Int."},{"key":"5025_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008834.pub3","author":"SC Palmer","year":"2013","unstructured":"Palmer\u00a0SC, Di Micco\u00a0L, Razavian\u00a0M et\u00a0al (2013) Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008834.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"5025_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10557-018-6802-1","volume":"32","author":"M Goicoechea","year":"2018","unstructured":"Goicoechea\u00a0M, Garcia de Vinuesa\u00a0S, Quiroga\u00a0B et\u00a0al (2018) Aspirin for primary prevention of cardiovascular disease and renal disease progression in chronic kidney disease patients: a multicenter randomized clinical trial (AASER study). Cardiovasc Drugs Ther 32:255\u2013263. https:\/\/doi.org\/10.1007\/s10557-018-6802-1","journal-title":"Cardiovasc Drugs Ther"},{"key":"5025_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","volume":"139","author":"TH Jafar","year":"2003","unstructured":"Jafar\u00a0TH, Stark\u00a0PC, Schmid\u00a0CH et al (2003) Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a\u00a0patient-level meta-analysis. Ann Intern Med 139:244\u2013252. https:\/\/doi.org\/10.7326\/0003-4819-139-4-200308190-00006","journal-title":"Ann Intern Med"},{"key":"5025_CR29","doi-asserted-by":"publisher","first-page":"f5680","DOI":"10.1136\/bmj.f5680","volume":"347","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2013","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration (2013) Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ 347:f5680. https:\/\/doi.org\/10.1136\/bmj.f5680","journal-title":"BMJ"},{"key":"5025_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","volume":"74","author":"E Ku","year":"2019","unstructured":"Ku\u00a0E, Lee\u00a0BJ, Wei\u00a0J, Weir\u00a0R (2019) Hypertension in CKD: core curriculum 2019. Am J Kidney Dis 74:120\u2013131. https:\/\/doi.org\/10.1053\/j.ajkd.2018.12.044","journal-title":"Am J Kidney Dis"},{"key":"5025_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.ki.5000247","volume":"69","author":"A Agarwal","year":"2006","unstructured":"Agarwal\u00a0A, Andersen\u00a0MJ (2006) Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 69:1175\u20131180","journal-title":"Kidney Int."},{"key":"5025_CR32","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYP.0000000000000065","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton\u00a0PK, Carey\u00a0RM, Aronow\u00a0WS et\u00a0al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA \/ASHASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology\/American heart association task force on clinical practice guideline. Hypertension 71:e13\u2013e115. https:\/\/doi.org\/10.1161\/HYP.0000000000000065","journal-title":"Hypertension"},{"key":"5025_CR33","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"The SPRINT Research Group","year":"2015","unstructured":"The SPRINT Research Group (2015) A randomized trial of intensive versus standard blood-pressure control. N\u00a0Engl J Med 373:2103\u20132116. https:\/\/doi.org\/10.1056\/NEJMoa1511939","journal-title":"N Engl J Med"},{"key":"5025_CR34","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams\u00a0B, Mancia\u00a0G, Spiering\u00a0W et\u00a0al (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension. J\u00a0Hypertens 36:1953\u20132041. https:\/\/doi.org\/10.1097\/HJH.0000000000001940","journal-title":"J Hypertens"},{"key":"5025_CR35","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","volume":"53","author":"D Fliser","year":"1998","unstructured":"Fliser\u00a0D, Pacini\u00a0G, Engelleiter\u00a0R et\u00a0al (1998) Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53:1343\u20131347. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00898.x","journal-title":"Kidney Int."},{"key":"5025_CR36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/ajkd.2002.30549","volume":"39","author":"MS Joy","year":"2002","unstructured":"Joy\u00a0MS, Cefalu\u00a0WT, Hogan\u00a0SL, Nachman\u00a0PH (2002) Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 39:297\u2013307. https:\/\/doi.org\/10.1053\/ajkd.2002.30549","journal-title":"Am. J. Kidney Dis."},{"issue":"4S","key":"5025_CR37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","volume":"98","author":"KDIGO Diabetes Working Group","year":"2020","unstructured":"KDIGO Diabetes Working Group (2020) KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 98(4S):S1\u2013115. https:\/\/doi.org\/10.1016\/j.kint.2020.06.019","journal-title":"Kidney Int."},{"key":"5025_CR38","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Lipid work group (2013) Lipids in CKD. https:\/\/kdigo.org\/guidelines\/lipids-in-ckd\/. Assessed 4\u00a0Dec 2020"},{"key":"5025_CR39","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent\u00a0C, Landray\u00a0MJ, Reith\u00a0C et al (2011) The effect of lowering LDL-cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomized placebo-controlled trial. Lancet 377:2181\u20132192. https:\/\/doi.org\/10.1016\/S0140-6736(11)60739-3","journal-title":"Lancet"},{"key":"5025_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner\u00a0C, Krane\u00a0V, Maerz\u00a0W et\u00a0al (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N\u00a0Engl J Med 353:238\u2013248. https:\/\/doi.org\/10.1056\/NEJMoa043545","journal-title":"N Engl J Med"},{"key":"5025_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","volume":"360","author":"BC Fellstroem","year":"2009","unstructured":"Fellstroem\u00a0BC, Jardine\u00a0AG, Schmieder\u00a0RE et\u00a0al (2009) Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N\u00a0Engl J Med 360:1395\u20131407. https:\/\/doi.org\/10.1056\/NEJMoa0810177","journal-title":"N Engl J Med"},{"key":"5025_CR42","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1600-6143.2004.0045.x","volume":"4","author":"AG Jardine","year":"2004","unstructured":"Jardine\u00a0AG, Holdaas\u00a0H, Fellstroem\u00a0B et al (2004) Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT study. Am J Transplant 4:988\u2013995. https:\/\/doi.org\/10.1111\/j.1600-6143.2004.0045.x","journal-title":"Am J Transplant"},{"key":"5025_CR43","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.kint.2018.01.030","volume":"93","author":"M Mafham","year":"2018","unstructured":"Mafham\u00a0M, Haynes\u00a0R (2018) PCSK9-inhibition: ready for prime time in CKD? Kidney Int 93:1267\u20131269. https:\/\/doi.org\/10.1016\/j.kint.2018.01.030","journal-title":"Kidney Int."},{"key":"5025_CR44","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIR.0000000000000183","volume":"131","author":"JB Washam","year":"2015","unstructured":"Washam\u00a0JB, Herzog\u00a0CA, Beitelshees\u00a0AL et\u00a0al (2015) Pharmacotherapy in chronic kidney patients presenting with acute coronary syndrome: a\u00a0scientific statement from the American heart association. Circulation 131:1123\u20131149. https:\/\/doi.org\/10.1161\/CIR.0000000000000183","journal-title":"Circulation"},{"key":"5025_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2369-14-229","volume":"14","author":"RF Dubin","year":"2013","unstructured":"Dubin\u00a0RF, Li\u00a0Y, He\u00a0J et al (2013) Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a\u00a0cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol 14:229. https:\/\/doi.org\/10.1186\/1471-2369-14-229","journal-title":"BMC Nephrol"},{"key":"5025_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.amjmed.2005.08.057","volume":"119","author":"JH Han","year":"2006","unstructured":"Han\u00a0JH, Chandra\u00a0A, Mulgund\u00a0J et al (2006) Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am J Med 119:248\u2013254. https:\/\/doi.org\/10.1016\/j.amjmed.2005.08.057","journal-title":"Am J Med"},{"key":"5025_CR47","doi-asserted-by":"publisher","first-page":"I270","DOI":"10.1161\/CIRCULATIONAHA.104.522623","volume":"112","author":"R Zakeri","year":"2005","unstructured":"Zakeri\u00a0R, Freemantle\u00a0N, Barkett\u00a0V et\u00a0al (2005) Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation 112:I270\u2013275. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.522623","journal-title":"Circulation"},{"key":"5025_CR48","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","volume":"382","author":"S Bangalore","year":"2020","unstructured":"Bangalore\u00a0S, Maron\u00a0DJ, O\u2019Brien\u00a0SM et\u00a0al (2020) Management of coronary disease in patients with advanced kidney disease. N\u00a0Engl J Med 382:1608\u20131618. https:\/\/doi.org\/10.1056\/NEJMoa1915925","journal-title":"N Engl J Med"},{"key":"5025_CR49","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ahj.2004.10.010","volume":"149","author":"JH Ix","year":"2005","unstructured":"Ix\u00a0JH, Mercado\u00a0N, Shlipak\u00a0MG et\u00a0al (2005) Association of chronic kidney disease with clinical outcomes after coronary revascularisation: the arterial revascularisation therapies study (ARTS). Am Heart\u00a0J 149:512\u2013559. https:\/\/doi.org\/10.1016\/j.ahj.2004.10.010","journal-title":"Am Heart J"},{"key":"5025_CR50","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.ajkd.2010.09.017","volume":"57","author":"DM Charytan","year":"2011","unstructured":"Charytan\u00a0DM, Varma\u00a0MR, Silbaugh\u00a0TS et al (2011) Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severly reduced GFR: results oft he Massachusetts data analysis center (mass-DAC) state registry. Am J Kidney Dis 57:202\u2013211. https:\/\/doi.org\/10.1053\/j.ajkd.2010.09.017","journal-title":"Am. J. Kidney Dis."},{"key":"5025_CR51","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0272-6386(04)00945-X","volume":"44","author":"T Pinkau","year":"2004","unstructured":"Pinkau\u00a0T, Mann\u00a0JP, Ndrepepa\u00a0G et\u00a0al (2004) Coronary revascularisation in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kidney Dis 44:627\u2013635","journal-title":"Am. J. Kidney Dis."},{"key":"5025_CR52","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/s0003-4975(02)03768-2","volume":"74","author":"LJ Dacey","year":"2002","unstructured":"Dacey\u00a0LJ, Liu\u00a0JY, Braxton\u00a0JH et al (2002) Long-term survival in dialysis patients after coronary bypass grafting. Ann Thorac Surg 74:458\u2013462. https:\/\/doi.org\/10.1016\/s0003-4975(02)03768-2","journal-title":"Ann Thorac Surg"},{"key":"5025_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MNH.0000000000000507","volume":"28","author":"J Voelkl","year":"2019","unstructured":"Voelkl\u00a0J, Cejka\u00a0D, Alesutan\u00a0I (2019) An overview of the mechanisms in vascular calcification during chronic kidney disease. Curr Opin Nephrol Hypertens 28:289\u2013296. https:\/\/doi.org\/10.1097\/MNH.0000000000000507","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"5025_CR54","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman\u00a0B, Wanner\u00a0C, Lachin\u00a0JM et\u00a0al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N\u00a0Engl J Med 373:2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"5025_CR55","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic\u00a0V, Jardine\u00a0MJ, Neal\u00a0B et\u00a0al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N\u00a0Engl J Med 380:2295\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1811744","journal-title":"N Engl J Med"},{"key":"5025_CR56","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink\u00a0HJL, Stefansson\u00a0BV, Correa-Rotter\u00a0R et al (2020) Dapagliflozin in patients with chronic kidney disease. N\u00a0Engl J Med 383:1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-021-05025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-021-05025-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-021-05025-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T03:08:55Z","timestamp":1623294535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-021-05025-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5025"],"URL":"https:\/\/doi.org\/10.1007\/s00059-021-05025-2","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"13 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"K.\u00a0Lopau and C.\u00a0Wanner declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}